Literature DB >> 11315973

Epidemiology of idiopathic intracranial hypertension in Israel.

A Kesler1, N Gadoth.   

Abstract

OBJECTIVES: To determine the incidence, demographic, and clinical features of Pseudo Tumor Cerebri (PTC)/Idiopathic Intracranial Hypertension (IIH) in Israel.
MATERIALS AND METHODS: The chairpersons of all neurology and ophthalmology departments in Israel were asked to complete questionnaires regarding patients diagnosed with PTC/IIH from 1998 through 1999. Each questionnaire contained details regarding patient's age, sex, country of birth, age at diagnosis, weight, height, presence of obesity, and the results of lumbar puncture, brain computed tomography, magnetic resonance imaging, and/or magnetic resonance venography.
RESULTS: Ninety-one patients with PTC/IIH were diagnosed during the years 1998 to 1999. Eighty-five (93.4%) patients were females and six (6.6%) patients were males. The calculated incidence of PTC/IIH in the Israeli general population was 0.57 to 0.94 per 100,000 persons, with incidences of 1.82 per 100,000 for women and 0.034 per 100,000 for men. The incidence for women during the childbirth years was 4.02 per 100,000. The female to male ratio was higher than previously reported for Western countries.
CONCLUSIONS: Although the population of Israel is a mixture of people originating from Eastern and Western countries, the incidence of PTC/IIH was found to be similar to that of Western countries. This finding is an additional support to the notion that PTC/IIH is more common in obese populations.

Entities:  

Mesh:

Year:  2001        PMID: 11315973     DOI: 10.1097/00041327-200103000-00003

Source DB:  PubMed          Journal:  J Neuroophthalmol        ISSN: 1070-8022            Impact factor:   3.042


  23 in total

Review 1.  [Characteristic neurological features, differential diagnostic criteria and medicinal treatment of idiopathic intracranial hypertension].

Authors:  K-D Willenborg; W Nacimiento
Journal:  Ophthalmologe       Date:  2015-10       Impact factor: 1.059

2.  Differing presenting features of idiopathic intracranial hypertension in the UK and US.

Authors:  R J Blanch; C Vasseneix; A Liczkowski; A Yiangou; A Aojula; J A Micieli; S P Mollan; N J Newman; V Biousse; B B Bruce; A Sinclair
Journal:  Eye (Lond)       Date:  2019-02-19       Impact factor: 3.775

3.  The incidence of idiopathic intracranial hypertension in Scotland: a SOSU study.

Authors:  Colin Goudie; Pushkar Shah; Justin McKee; Barny Foot; Obaid Kousha; Andrew Blaikie
Journal:  Eye (Lond)       Date:  2019-04-30       Impact factor: 3.775

Review 4.  Idiopathic intracranial hypertension in the Middle East: A growing concern.

Authors:  Sumayya J Almarzouqi; Michael L Morgan; Andrew G Lee
Journal:  Saudi J Ophthalmol       Date:  2014-09-28

Review 5.  Headache attributable to nonvascular intracranial disorders.

Authors:  Mark Obermann; Dagny Holle; Steffen Naegel; Hans-Christoph Diener
Journal:  Curr Pain Headache Rep       Date:  2011-08

6.  Emergency department utilization among individuals with idiopathic intracranial hypertension.

Authors:  Sean Murphy; Daniel L Friesner; Robert Rosenman; Carin S Waslo; Johnathan Au; Emanuel Tanne
Journal:  Int J Health Care Qual Assur       Date:  2019-02-11

7.  Re-evaluating the Incidence of Idiopathic Intracranial Hypertension in an Era of Increasing Obesity.

Authors:  Khin P Kilgore; Michael S Lee; Jacqueline A Leavitt; Bahram Mokri; David O Hodge; Ryan D Frank; John J Chen
Journal:  Ophthalmology       Date:  2017-02-07       Impact factor: 12.079

Review 8.  Epidemiology and risk factors for idiopathic intracranial hypertension.

Authors:  John Chen; Michael Wall
Journal:  Int Ophthalmol Clin       Date:  2014

9.  Risk factors for idiopathic intracranial hypertension in men: a case-control study.

Authors:  J Alexander Fraser; Beau B Bruce; Janet Rucker; Lisa-Ann Fraser; Edward J Atkins; Nancy J Newman; Valérie Biousse
Journal:  J Neurol Sci       Date:  2009-11-30       Impact factor: 3.181

10.  Idiopathic intracranial hypertension in men.

Authors:  B B Bruce; S Kedar; G P Van Stavern; D Monaghan; M D Acierno; R A Braswell; P Preechawat; J J Corbett; N J Newman; V Biousse
Journal:  Neurology       Date:  2008-10-15       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.